International Journal of Molecular Medicine · 2001 · 24 citations · 33 references
MedicineImmunologyOncologyImmunotherapyMolecular OncologyNeuro-oncologyBacterial ToxinsCancer ImmunotherapyPhage DisplayAntibody - Toxin ConjugatesBacterial Antibody ExpressionBacterial ExotoxinsCell Viability AssaysNeuroblastoma BiologyPhage Display LibrariesPhage Display Screening
Since the disialoganglioside GD2 is abundantly present on the surface of neuroblastoma cells, we constructed a new recombinant immunotoxin for possible clinical use in patients with neuroblastoma. A functional 14.18 scFv-phage was obtained by selection of an anti-GD2 hybridoma derived phage antibody mini-library on the neuroblastoma-derived, GD2-expressing cell line IMR5. By insertion into the bacterial expression vector pBM1.1 the selected scFv was fused to a deletion mutant of Pseudomonas exotoxin A (ETA'). Periplasmically expressed 14.18(scFv)-ETA' bound to the GD2 expressing cell line IMR5, but not to the GD2 negative Hodgkin-derived cell line L540Cy as documented by ELISA and flow cytometry. The recombinant immunotoxin (rIT) inhibited cell viability of IMR5 cells by 50% at concentrations (IC(50)) of 0.326 microg/ml. This recombinant immunotoxin will be further investigated in vivo for its value as a new immunotherapeutic agent for the treatment of patients with neuroblastoma.
33
James D. Marks, Hennie R. Hoogenboom, Timothy P. Bonnert et al. · Journal of Molecular Biology · 1991 · 1.6K citations
James S. Huston, Dennis J. Levinson, M Mudgett-Hunter et al. · Proceedings of the National Academy of Sciences · 1988 · 1.6K citations · Full text
Gene Splicing by Overlap Extension: Tailor-Made Genes Using the Polymerase Chain Reaction
Robert M. Horton, Zeling Cai, Steffan N. Ho et al. · BioTechniques · 2013 · 1.3K citations · Full text